Both in Pharmaceuticals
Amylyx Pharmaceuticals vs IDEAYA Biosciences
Over the past year AMLX returned +96.5% and IDYA returned +39.2%; their daily moves had a correlation of 0.33.
AMLX +96.5% IDYA +39.2%Growth of $1, one year, split-adjusted
| Metric | AMLX | IDYA |
|---|---|---|
| Price | $29.28 | $37.86 |
| Market cap | $3.74B | $3.65B |
| Today | −1.91% | −0.94% |
| 1 month | −15.7% | −5.6% |
| 6 months | +129.5% | +20.4% |
| Year to date | +142.4% | +9.5% |
| 1 year | +101.7% | +41.1% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | 100.0% |
| Net margin | — | −1269.6% |
| P/E (TTM) | — | — |
| Price / sales | — | 15.6× |
| Net cash | $250.8M | $829.0M |
| Dividend yield | — | — |
| Volatility (60d) | 116.4% | 35.7% |
| Short % of float | 14.0% | 11.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).